Minimally important differences for interpreting EORTC QLQ-C30 scores in patients with advanced breast cancer

Musoro, JZ, Coens, C, Frederic, F et al. (9 more authors) (2019) Minimally important differences for interpreting EORTC QLQ-C30 scores in patients with advanced breast cancer. JNCI: Journal of the National Cancer Institute, 3 (3). pkz037. ISSN 0027-8874

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s) 2019. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Keywords: Health-related quality of life (HRQOL); EORTC QLQ-C30; Minimally important difference (MID); Advanced Breast cancer
Dates:
  • Published: September 2019
  • Accepted: 20 May 2019
  • Published (online): 4 June 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Patient Centred Outcomes Research
Depositing User: Symplectic Publications
Date Deposited: 28 Jun 2019 11:21
Last Modified: 15 Aug 2019 13:59
Status: Published
Publisher: Oxford University Press
Identification Number: https://doi.org/10.1093/jncics/pkz037

Download

Filename: pkz037.pdf

Licence: CC-BY-NC 4.0

Share / Export

Statistics